دورية أكاديمية
Sarcopenia diagnosis in patients receiving hemodialysis: Agreement among different consensuses.
| العنوان: | Sarcopenia diagnosis in patients receiving hemodialysis: Agreement among different consensuses. |
|---|---|
| المؤلفون: | Rosa CSC; Department of Physical Education, São Paulo State University, Bauru, Brazil., Ribeiro HS; Faculty of Physical Education, University of Brasília, Brasília, Brazil.; Research Center in Sports Sciences, Health Sciences and Human Development, University of Maia, Porto, Portugal., Vogt BP; Graduate Program in Health Sciences, School of Medicine, Federal University of Uberlandia, Uberlandia, Brazil., Sakkas GK; School of Physical Education, Sport Science and Dietetics, University of Thessaly, Trikala, Greece.; School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom., Monteiro HL; Department of Physical Education, São Paulo State University, Bauru, Brazil. |
| المصدر: | Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition [Nutr Clin Pract] 2022 Dec; Vol. 37 (6), pp. 1348-1355. Date of Electronic Publication: 2021 Dec 30. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley Country of Publication: United States NLM ID: 8606733 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-2452 (Electronic) Linking ISSN: 08845336 NLM ISO Abbreviation: Nutr Clin Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2018- : [Hoboken, NJ] : Wiley Original Publication: [Baltimore, Md. : Williams & Wilkins, c1986- |
| مواضيع طبية MeSH: | Sarcopenia*/diagnosis , Sarcopenia*/epidemiology , Sarcopenia*/etiology, Humans ; Male ; Female ; Aged ; Middle Aged ; Hand Strength/physiology ; Consensus ; Absorptiometry, Photon ; Renal Dialysis/adverse effects ; Prevalence |
| مستخلص: | Background: There are many consensuses to diagnose sarcopenia, and their agreement in patients receiving hemodialysis (HD) is not clear. We described the sarcopenia prevalence in patients receiving HD using different consensuses and analyzed their level of agreement. Methods: Sixty-seven patients (43 men, 55 ± 14.6 years) were evaluated for appendicular skeletal muscle mass using dual-energy x-ray absorptiometry and muscle strength using handgrip strength. Patients were classified according to different sarcopenia consensuses (European Working Group on Sarcopenia in Older People [EWGSOP], Revised EWGSOP [EWGSOP2], Foundation for the National Institutes of Health Project [FNIH], and Asian Working Group for Sarcopenia 2019 [AWGS2]). Kappa analysis identified the level of agreement. Results: The prevalence of sarcopenia ranged from 1.5% to 11.9% depending on the sarcopenia consensus. The agreement between the different consensuses ranged from poor to almost perfect. FNIH and EWGSOP showed the lowest agreement (κ = 0.20; 95% CI, -0.14 to 0.54; P < 0.05), whereas EWGSOP2 and AWGS2 had the largest κ = 0.90 (95% CI, 0.71 to 1.00; P < 0.001). When stratified by age (≥60 years), the sarcopenia prevalence was higher in the older group (27% vs 2%; P = 0.004). In addition, male participants seemed to be more prone to sarcopenia compared with female counterparts, but this difference was not statistically confirmed (16% vs 4%; P = 0.242). Conclusion: The sarcopenia consensuses showed from poor to almost perfect agreement, which varied the sarcopenia prevalence rates in patients receiving HD. EWGSOP2 and AWGS2 showed the largest agreement. (© 2021 American Society for Parenteral and Enteral Nutrition.) |
| References: | Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77-90. Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18(3):254-262. McIntyre CW, Selby NM, Sigrist M, Pearce LE, Mercer TH, Naish PF. Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant. 2006;21(8):2210-2216. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412-423. Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. 2015;30(10):1718-1725. Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging. 2014;18(7):710-717. de SVA, de OD, Mansur HN, Fernandes NMS, Bastos MG. Sarcopenia in chronic kidney disease. J Bras Nefrol. 2015;37(1):98-105. Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017;8(1):57-68. Carrero JJ, Johansen KL, Lindholm B, Stenvinkel P, Cuppari L, Avesani CM. Screening for muscle wasting and dysfunction in patients with chronic kidney disease. Kidney Int. 2016;90(1):53-66. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391-398. Carrero JJ, Chmielewski M, Axelsson J, et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr. 2008;27(4):557-564. Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9(10):1720-1728. Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon. 2016;8(3):e37443. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34(4):1347-1372. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69A(5):547-558. https://doi.org/10.1093/gerona/glu010. Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. Wang W, Wang Z, Faith MS, Kotler D, Shih R, Heymsfield SB. Regional skeletal muscle measurement: evaluation of new dual-energy X-ray absorptiometry model. J Appl Physiol. 1999;87(3):1163-1171. Lee W-J, Liu L-K, Peng L-N, Lin M-H, Chen L-K. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan Longitudinal Aging Study. J Am Med Dir Assoc. 2013;14(7):528-535. Landis JR, Koch GG. An Application of hierarchical Kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33(2):363. Slee A, McKeaveney C, Adamson G, et al. Estimating the prevalence of muscle wasting, weakness, and sarcopenia in hemodialysis patients. J Ren Nutr. 2020;30(4):313-321. Tangvoraphonkchai K, Hung R, Sadeghi-Alavijeh O, Davenport A. Differences in prevalence of muscle weakness (sarcopenia) in haemodialysis patients determined by hand grip strength due to variation in guideline definitions of sarcopenia. Nutr Clin Pract. 2018;33(2):255-260. Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, Mohamed A, Davenport A. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity. J Hum Nutr Diet. 2018;31(5):689-696. Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504-516. Watanabe H, Enoki Y, Maruyama T. Sarcopenia in chronic kidney disease: factors, mechanisms, and therapeutic interventions. Biol Pharm Bull. 2019;42(9):1437-1445. da Silva MZC, Vogt BP, Reis NS do C, Caramori JCT. Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis?. Eur J Clin Nutr. 2019;73(8):1209-1211. Kooman JP, Kotanko P, Schols AMWJ, Shiels PG, Stenvinkel P. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10(12):732-742. Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013;62(2):339-351. Pagotto V, Silveira EA. Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr. 2014;59(2):288-294. Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2017;26(3):219-228. Johansen KL, Painter P, Kent-Braun J, et al. Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Kidney Int. 2001;59(3):1121-1127. Rosa CSC, Bueno DR, Souza GD, et al. Factors associated with leisure-time physical activity among patients undergoing hemodialysis. BMC Nephrol. 2015;16(1):192. Sawant A, House AA, Overend TJ. Anabolic effect of exercise training in people with end-stage renal disease on hemodialysis: a systematic review with meta-analysis. Physiother Can. 2014;66(1):44-53. https://doi.org/10.3138/ptc.2012-59. Rosa CSC, Giannaki CD, Krase A, et al. Effects of 12 months of detraining on health-related quality of life in patients receiving hemodialysis therapy. Int Urol Nephrol. 2020;52(9):1771-1778. |
| فهرسة مساهمة: | Keywords: chronic kidney disease; hemodialysis; muscle mass; muscle strength; sarcopenia |
| تواريخ الأحداث: | Date Created: 20211231 Date Completed: 20221109 Latest Revision: 20221109 |
| رمز التحديث: | 20240829 |
| DOI: | 10.1002/ncp.10813 |
| PMID: | 34970778 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1941-2452 |
|---|---|
| DOI: | 10.1002/ncp.10813 |